Related references
Note: Only part of the references are listed.Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia
Craig A. Friesen et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Non-ulcer dyspepsia and duodenal eosinophilia:: An adult endoscopic population-based case-control study
Nicholas J. Talley et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Generation of Th1 and Th2 chemokines by human eosinophils:: Evidence for a critical role of TNF-α
Lin Ying Liu et al.
JOURNAL OF IMMUNOLOGY (2007)
Pathophysiological role of mast cells in collagen-induced arthritis: Study with a cysteinyl leukotriene receptor antagonist, montelukast
Naotaka Shiota et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
The effect of montelukast on soluble interleukin-2 receptor and tumor necrosis factor α in pediatric asthma
Murat Can et al.
ALLERGY AND ASTHMA PROCEEDINGS (2006)
Effects of leukotriene receptor antagonists on monocyte chemotaxis, p38 and cytoplasmic calcium
Chih-Hsing Hung et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2006)
Functional gastrointestinal disorders and mast cells: implications for therapy
G Barbara et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2006)
Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis
M. Peters-Golden et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2006)
Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis
I Stelmach et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2005)
Diagnosing functional abdominal pain with the Rome II criteria: Parent, child, and clinician agreement
JV Schurman et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2005)
Effect of montelukast on nuclear factor κB activation and proinflammatory molecules
S Maeba et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2005)
Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia
CA Friesen et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2004)
Pharmacokinetics of montelukast in asthmatic patients 6 to 24 months old
E Migoya et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Gastric Mucosal Mast Cells Are Increased in Helicobacter pylori-Negative Functional Dyspepsia
Wendy Hall et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2003)
Montelukast: Use in pediatric patients with eosinophilic gastrointestinal disease
JA Vanderhoof et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2003)
Eosinophilic oesophagitis: a novel treatment using Montelukast
SEA Attwood et al.
GUT (2003)
Actions of cysteinyl leukotrienes in the enteric nervous system of guinea-pig stomach and small intestine
SM Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Neuroimmune interactions in guinea pig stomach and small intestine
SM Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma
PS Thomas et al.
THORAX (2002)
Activated duodenal mucosal eosinophils in children with dyspepsia: A pilot transmission electron microscopic study
CA Friesen et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2002)
Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists
EA Mellor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis
DA Schwartz et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease
JS Erjefält et al.
THORAX (2001)
Share Paper
